PRELIMINARY AGREEMENTPreliminary Agreement • April 25th, 2024
Contract Type FiledApril 25th, 2024the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • January 30th, 2024
Contract Type FiledJanuary 30th, 2024the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • November 9th, 2023
Contract Type FiledNovember 9th, 2023the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • October 4th, 2023
Contract Type FiledOctober 4th, 2023the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • July 13th, 2023
Contract Type FiledJuly 13th, 2023the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • July 22nd, 2022
Contract Type FiledJuly 22nd, 2022the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • May 28th, 2022
Contract Type FiledMay 28th, 2022the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • April 4th, 2022
Contract Type FiledApril 4th, 2022the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other
PRELIMINARY AGREEMENTPreliminary Agreement • January 8th, 2022
Contract Type FiledJanuary 8th, 2022the Managing Director, Pharmaceutical Corporation (Indian Medicines) Kerala Ltd. Thrissur (herein after referred as the Managing Director) of the one part and Shri (herein after referred to as the bounden) of the other